The United States Hereditary Angioedema Market is supported by advanced diagnostic capabilities, substantial investment in rare disease research, and the increasing availability of innovative on-demand and preventive treatments. Growing patient awareness, improved disease management programs, and the presence of specialized treatment centers are contributing to better access to therapeutic...